SEC Form 4 · accession 0001144204-19-001262
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Bright
Officer — President, International
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2019 | S | 1,313 | $104.93 | D | 18,807 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.